Gregory Glover, a registered patent attorney and non-practicing physician, is one of the nation’s experts on the complex interaction of food and drug laws and intellectual property. Greg represents life sciences companies, investors, and trade associations on strategic product development issues, including: market protection analyses based on intellectual property laws, FDA regulations, and patent portfolio evaluations. Greg has also testified on behalf of the research-based pharmaceutical industry before committees of both houses of Congress on legislative matters affecting market protection for pharmaceutical, biotechnology and medical device products. In addition, Greg has made presentations on behalf of research-based companies on market protection issues before the Food and Drug Administration, the Federal Trade Commission, and the Department of Justice.

Greg leads the activities of Pharmaceutical Law Group along with Project Consultants, who provide additional legal and business expertise.